جستجوی استاد راهنمای دانشگاهی

W. Steven Wardمشاهده پروفایل

استاد

• Sperm Chromatin Structure
• Early Embryonic DNA Replication
• Biology of Early Folliculogenesis
• +۲ مورد دیگر

W. Steven Ward is a Professor and Director of the Institute for Biogenesis Research (IBR) at the John A. Burns School of Medicine, University of Hawaii. He holds dual affiliations with the Department of Anatomy, Biochemistry and Physiology and the Department of Obstetrics, Gynecology & Women's Health . Education: B.S. in Chemistry, American University of Beirut M.S. in Biochemistry, American University of Beirut Ph.D. in Biochemistry, Vanderbilt University (1985) Research Interests Dr. Ward's work focuses on chromatin structure during spermiogenesis and embryogenesis, particularly the organization of DNA in sperm cells. His lab developed a widely accepted model of sperm chromatin structure based on loop domains, which are critical for paternal DNA replication in embryos. Additional research explores ORC4 protein's role in chromatin expulsion during meiosis and erythrocyte maturation, alongside Exoc5's importance in folliculogenesis. Current projects span three areas: sperm chromatin structure, early embryonic DNA replication, and folliculogenesis biology. Publication Trends His 15 most recent articles (2023–1993) emphasize reproductive biology, developmental genetics, and molecular mechanisms of chromatin organization. Key themes include sperm DNA fragmentation, interspecies comparisons (hamster/mouse models), and the functional implications of chromatin expulsion in oocytes and red blood cells. Collaborative clinical research with urologists and geneticists is evident, particularly in studies linking chromatin structure to fertility outcomes. Grants & Leadership Dr. Ward has maintained continuous NIH funding since 1991 and led a $16M COBRE grant (2009–2025) to develop research capacity at the IBR. As Chief of the Obstetrics and Gynecology Division of Research (2014–), he bridges clinical and basic science, notably through studies on post-vasectomy DNA fragmentation and its developmental impacts. Labs & Teams As IBR director, he leads a multidisciplinary team investigating reproductive biogenesis, including spermatogenesis, oogenesis, and embryonic chromatin dynamics. The lab employs molecular, genetic, and clinical research approaches, often in collaboration with urology and obstetrics departments.

Kevin Edgarمشاهده پروفایل

استاد

• Polysaccharide Chemistry
• Drug Delivery Systems
• Tissue Engineering
• +۷ مورد دیگر

Kevin Edgar is a Professor of Biomaterials and Bioprocessing and Director of the ICTAS Bio-Based Materials Center at Virginia Tech's College of Natural Resources and Environment, Department of Sustainable Biomaterials. With a Ph.D. in Organic Chemistry from Duke University (1979) and a B.S. in Chemistry from Bucknell University (1975), he has established himself as a leading researcher in polysaccharide chemistry and sustainable biomaterials. Dr. Edgar's research focuses on designing and creating derivatives of natural polysaccharides to address demanding performance requirements, exploring structure-property-performance relationships for applications including drug-delivery systems, tissue engineering, biodegradable plastics, polymer compatibilization, hydrogels, and block copolymers. His work specifically targets novel methods to control and utilize the nanostructure of polysaccharides, with emphasis on regioselective substitution reactions of complex polysaccharides. He investigates how to effectively utilize natural polysaccharides to address societal needs, leveraging their diverse natural functions from structural support to information storage. Analysis of his recent publications reveals a strong focus on hydrogel development, drug delivery systems, and polysaccharide modification techniques. His work spans fundamental chemistry of polysaccharides to applied pharmaceutical and medical applications, with particular emphasis on creating sustainable alternatives to fossil fuel-based materials. The research demonstrates consistent innovation in regioselective synthesis methods and structure-property relationships of polysaccharide derivatives. 2023 Appointed to Virginia Tech Academy of Faculty Leadership 2022 Virginia Tech College of Natural Resources and Environment Outstanding Graduate Student Mentor Award 2016 Anselme Payen Award for outstanding professional contributions to cellulose science 2010 Named Fellow of the ACS Division of Cellulose and Renewable Materials 2009 Named Fellow of ACS (inaugural class of ACS Fellows) Dr. Edgar has mentored numerous graduate students through their Ph.D. and Master's research, with many receiving prestigious awards including multiple Eastman Awards for outstanding graduate students. His research has been supported by significant grants from NSF, USDA NIFA, and other funding agencies. He leads the ICTAS Bio-Based Materials Center and co-directs the Infectious Disease Interdisciplinary Graduate Education Program, demonstrating strong leadership in interdisciplinary research. His lab actively develops sustainable biomaterials with applications in drug delivery, tissue engineering, and environmental health.

Camille Berthelotمشاهده پروفایل

پژوهشگر

• Comparative Functional Genomics
• Evolutionary Genomics
• Gene Regulation
• +۱۲ مورد دیگر

Camille Berthelot is a Principal Investigator and head of the Comparative Functional Genomics research group at the Institut Pasteur in Paris, France. Her work lies at the intersection of evolutionary biology, genomics, and reproductive physiology, with a focus on understanding how genomic changes drive evolutionary innovations in vertebrates, particularly the evolution of menstruation in primates. Her research leverages cutting-edge technologies including single-cell RNA sequencing, organoid models, and computational frameworks to compare gene expression and regulation across species such as humans, macaques, and mice. She investigates how evolutionary changes in gene function contribute to novel traits and how these relate to diseases like endometriosis. A major focus is the use of menstrual fluid as a non-invasive biomarker source for endometriosis, a direction highlighted in her systematic review published in Reproductive Biology and Endocrinology . Her recent publications span high-impact journals such as Science , Genome Research , and Nature Ecology & Evolution , covering topics from teleost fish phylogeny to regulatory evolution in mole-rats. These works reveal a consistent trend in using comparative genomics to decode deep evolutionary questions, often in collaboration with institutions like QMUL and INSERM. ERC Starting Grant (EVOMENS) – Decoding the genetics of menstruation evolution in primates Collaborative project on hypoxia adaptation in mole-rats Development of bioinformatics tools like FINSURF for non-coding variant classification She actively mentors a team of postdocs, PhD students, and master’s interns, including Claire Lavergne, Leo Zeitler, and Eulalie Liorzou. Former members such as Malgorzata Gazda and Axelle Brulport have gone on to independent academic positions, reflecting her role in training next-generation scientists. Camille Berthelot returned from maternity leave in June 2024 and remains actively engaged in research, publication, and team leadership at the Institut Pasteur.

• Computational Chemistry
• Molecular Modeling
• Structural Biology
• +۵ مورد دیگر

Dr. Magdalena Ślusarz serves as an Adjunct Professor in the Department of Theoretical Chemistry at the Faculty of Chemistry, University of Gdańsk. Her research focuses on computational approaches to structural biology problems, particularly in viral immunomodulation and receptor-ligand interactions. Her research interests span computational chemistry , molecular modeling of protein structures , and structural analysis of viral immune evasion mechanisms . She specializes in applying molecular dynamics simulations, NMR spectroscopy data interpretation, and UNRES force field methodologies to study herpesvirus proteins (particularly UL49.5), opioid receptor interactions, and vasopressin receptor systems. Her work bridges theoretical chemistry with biomedical applications including viral pathogenesis and neuropharmacology. Analysis of her recent publications reveals a strong focus on herpesvirus immunomodulation mechanisms (2023-2024), particularly how viral proteins hijack cellular degradation pathways. Earlier work demonstrates expertise in computational structural biology methodologies including UNRES force field development for membrane proteins (2019) and protein structure prediction (2016-2020). Her research consistently applies molecular modeling to solve biomedical problems ranging from viral immune evasion to neuropharmacology. Dr. Ślusarz maintains active research in the Laboratory of Molecular Modeling at the University of Gdańsk, where she applies computational approaches to protein structure-function relationships. Her work involves collaborations across international research teams, particularly evident in large-scale projects like the WeFold consortium for protein structure prediction.

• Chiral Recognition
• Enantiomeric Separations
• Ionic Liquids
• +۵ مورد دیگر

Daniel W Armstrong is a Professor at the University of Texas at Arlington in the Department of Chemistry and Biochemistry. With over 35 years of experience, he is a pioneering figure in chiral recognition, enantiomeric separations, and the biological relevance of D-amino acids. His work has led to over 740 publications, 35 patents, and 560 invited seminars worldwide. Developed first chiral recognition mechanism by cyclodextrins First to use macrocyclic antibiotics as chiral selectors Synthesized most new ionic liquids (ILs) globally Created ultra-fast separation techniques now standard in analytical chemistry Contributed to FDA 1992 guidelines on chiral drug separation His research focuses on chiral separations, ionic liquids, and the role of D-amino acids in biological systems. He has commercialized over 30 HPLC and GC columns, transforming analytical chemistry and pharmaceutical analysis. Recent publications demonstrate continued innovation in chiral chromatography, biomarker analysis, and AI-driven separation optimization. His grants include industry collaborations with Merck, Alcon, and Sigma-Aldrich, emphasizing practical applications of his work. Scientific honors include multiple lifetime achievement awards, fellowships in the Royal Society of Chemistry and American Chemical Society, the Chirality Medal, and induction into the National Academy of Inventors. He has mentored over 100 PhD students, many from first-generation college backgrounds.

Dirk Schneiderمشاهده پروفایل

استاد

• Membrane Biochemistry
• Biophysics
• Protein-Lipid Interactions
• +۴ مورد دیگر

Prof. Dirk Schneider is a Full Professor (W3) of Biochemistry at Johannes Gutenberg University Mainz since 2010, with previous appointments at the University of Freiburg (2003-2009) and postdoctoral training at Yale University. His research spans membrane biochemistry, biophysics, and transmembrane protein folding/assembly, focusing on thylakoid membrane biogenesis and protein-lipid interactions in cyanobacteria and chloroplasts. Current roles: Full Professor, University Mainz Previous roles: Assistant Professor (W1), University of Freiburg Education: PhD (summa cum laude) from Ruhr-University Bochum His research interests include: Membrane protein folding and stability ESCRT-III/Vipp1/PspA family structural dynamics ABC transporter activity regulation (e.g., BmrA) Protein-lipid interaction mechanisms Thylakoid membrane remodeling Comparative membrane biology between prokaryotes and eukaryotes Development of spectroscopic and computational methods Recent publications reveal trends in bacterial membrane remodeling (SynDLP, PspA), lipid effects on transporter activity (BmrA), and IM30/Vipp1-mediated membrane fusion. His work combines structural biology, biophysics, and functional assays to elucidate membrane dynamics. Awarded the Dr. Heinrich Kost Award (2001) and Leopoldina Fellowship (2001) , he has held leadership roles including Study Section Speaker (2010-2014) , Director of Institute of Pharmacy and Biochemistry (2013-2015) , and Dean of Faculty of Chemistry (2015-2020) . His scientific advisory roles include editorial board memberships and study section leadership.

Fernanda Cardosoمشاهده پروفایل

دانشگاهی

• Venom peptide-based biodiscovery
• Therapeutics development for neurological disorders
• Ion channel modulators
• +۶ مورد دیگر

Dr Fernanda Cardoso is a Senior Research Fellow at the Institute for Molecular Bioscience, University of Queensland. She holds dual Brazilian-Australian citizenship and specializes in venom peptide-based biodiscovery and therapeutics development for neurological disorders such as chronic pain, motor neuron disease (MND), and irritable bowel syndrome (IBS). Her interdisciplinary expertise spans neuropharmacology, medicinal chemistry, and drug discovery. Education: Bachelor's, Universidade Federal de Minas Gerais (UFMG) MSc in Molecular Pharmacology, UFMG PhD in Biochemistry and Immunology, UFMG Research Interests: Mechanisms and therapies for chronic pain/visceral pain/IBS Neurodegeneration pathophysiology and drug development Venom pharmacology of spiders, cone snails, and snakes Structure-function relationships of venom peptides Voltage-gated ion channel modulation Grants & Projects: Current: Peptide Inhibitors Targeting Sodium Channels (2023-2026) Past: Multifunctional analgesic inhibitors (2020-2023), IBS pain therapies (2018-2019) Supervision: Recently advised 14 students on projects including ALS therapies, venom peptide characterization, and ion channel modulation. Current openings focus on venom bioactives and neurological disorder treatments. Achievements: Pioneered venom-based ion channel modulator discovery, identified neuroprotective venom peptides, and developed a schistosomiasis vaccine candidate. Her work bridges basic research with clinical applications for global health challenges.

Thomas V. O'Halloranمشاهده پروفایل

استاد

• Metallomics
• Metal Regulation
• Cancer Therapeutics
• +۴ مورد دیگر

Thomas V. O'Halloran is the Morrison Professor of Chemistry at Northwestern University, holding dual appointments in Molecular Biosciences and the Chemistry of Life Processes Institute (CLP). He directs the CLP Institute and serves as Associate Director of Basic Sciences at the Robert H. Lurie Comprehensive Cancer Center. His research integrates bioinorganic chemistry with molecular biology to study transition metal (zinc, copper, iron) regulation in biological systems. Dr. O’Halloran earned his B.S. from the University of Missouri (1979) and Ph.D. from Columbia University (1985). His work focuses on metalloregulatory proteins, metallochaperones, and metallome dysregulation in disease. Notable contributions include discovering zinc sparks during fertilization, developing arsenoplatin anticancer complexes, and pioneering nanobin drug delivery systems. Research interests span metallomics, metal trafficking in cancer, and zinc's role in developmental processes. His lab employs interdisciplinary methods: X-ray crystallography, fluorescence microscopy, ICP-MS metallomics, and nanoparticle engineering. Key projects include targeting ovarian cancer with uPA-receptor nanobins and understanding copper homeostasis in fungal pathogens. Education: B.S. University of Missouri (1979), Ph.D. Columbia University (1985) Affiliations: CLP Institute, Robert H. Lurie Cancer Center Key Techniques: Metal speciation analysis, nanoparticle synthesis, live-cell imaging His 150+ publications span Science , Nature Chemistry , and Angewandte Chemie . Awards include the Royal Society of Chemistry Dalton Award and NIH MERIT award.

Eric C. Boltonمشاهده پروفایل

دانشیار

• Cancer
• Developmental Biology
• Endocrinology
• +۴ مورد دیگر

Eric C. Bolton is an Associate Professor in the Department of Molecular & Integrative Physiology at the University of Illinois, affiliated with the School of Molecular & Cellular Biology. His research focuses on understanding the molecular mechanisms of prostate development and neoplasia, particularly the role of androgen receptor (AR) signaling in hormone-dependent cancers and developmental pathways. He holds a PhD from Johns Hopkins University and postdoctoral training at UCSF. Research interests include the AR's role in cell proliferation/differentiation, crosstalk with growth factor pathways, and the transition from normal prostate development to cancer. He employs mouse models and organ culture systems to study prostate gland morphogenesis and AR-mediated stress responses. Recent work also explores KCNQ2 mutations linked to epileptic encephalopathy, highlighting interdisciplinary research into neuroendocrine mechanisms. Teaching includes courses on human disease mechanisms and cancer pathophysiology. Bolton's lab investigates novel therapeutic targets for prostate cancer, including non-competitive AR inhibitors and pathways regulating cellular stress responses.

Peter Verwilstمشاهده پروفایل

دانشیار

• Medicinal Chemistry
• Allosteric Modulation of Enzyme Targets
• Fluorescent Markers for Neurodegenerative Diseases
• +۵ مورد دیگر

Peter Verwilst is an Associate Professor at the Medicinal Chemistry division of the Rega Institute for Medical Research , part of KU Leuven 's Department of Pharmaceutical and Pharmacological Sciences. He leads projects in allosteric modulation of enzyme targets , fluorescent markers for neurodegenerative diseases , and novel antimicrobial development , particularly focusing on Gram-negative bacteria and HIV-related therapies. His research integrates computational modeling , chemical synthesis , and fluorescent probe design . He supervises PhD students including Margaux Billen , Eline Goffin , and Radu Bulai , and collaborates with institutions like Masaryk University and the Institut Pasteur de Lille. Current projects explore CCR5 signaling modulators , PurK inhibitors , and DNA-Encoded Libraries for P. aeruginosa antibiotics. Scientific awards include supporting students like Radu Bulai in obtaining FWO PhD Fellowships . His teaching includes Organische chemie I & II and Medicinale chemie courses. The lab recently celebrated securing a C1 grant and welcomes international collaborations.

Yann Pontyمشاهده پروفایل

پژوهشگر

• RNA Folding
• RNA Design
• RNA Evolution
• +۹ مورد دیگر

Yann Ponty is a tenured CNRS Researcher at the Computer Science Department (LIX) of École Polytechnique (Institut Polytechnique de Paris, France). He leads the AMIBio team and serves as Deputy Director of LIX. His work focuses on developing bioinformatics methods at the intersection of computer science, mathematics, and molecular biology, particularly for RNA structure prediction, design, and evolution. He holds leadership roles in the ISCB Board of Directors (2025-2027) and the HDR referent for the IDIA department (CS&Interactions) at IP Paris. Research Interests: RNA folding/design/evolution, RNA-RNA/RNA-protein interactions, random generation, enumerative combinatorics, discrete algorithms, parameterized complexity, RNA visualization Key Contributions: Developed algorithms for RNA inverse folding, pseudoknot modeling, and dynamic programming optimization Collaborations: Partnerships with institutions like Simon Fraser University, Boston College, and Université Paris-Saclay His recent publications (15 most recent) span RNA structure prediction, pseudoknot partition functions, linear-time inverse folding algorithms, and parameterized sampling techniques. The work emphasizes dynamic programming, combinatorial approaches, and integration of experimental data for improving RNA modeling. Scientific awards include election to the ISCB Board of Directors (2025-2027) and leadership roles in academic networks like GdR BIM. He actively contributes to software development (VARNA, RNANR, SPARCS, IncaRNAtion, RNARedPrint) and serves as Associate Editor for Bioinformatics (OUP). Teaching engagements include graduate-level courses in combinatorial optimization, RNA bioinformatics, and algorithms at Université Paris-Saclay and École Polytechnique.

Ian J. Mohrمشاهده پروفایل

استاد

• Post-transcriptional gene regulation
• Virology
• RNA Biology
• +۳ مورد دیگر

Ian J. Mohr, PhD is a Professor in the Department of Microbiology at NYU Grossman School of Medicine. His research focuses on post-transcriptional control of gene expression during virus infection, intersecting virology, RNA biology, and genome integrity. Education PhD in Molecular Biology from Stony Brook University Postdoctoral Training at University of California, Berkeley (Molecular and Cell Biology) Research Interests Mohr's lab investigates how physiological stress and viral infections dysregulate translational control, RNA metabolism, and gene expression. Key areas include: RNA modifications (e.g., m6A) in viral replication Translational control during viral infection Host antiviral responses targeting mRNA decay Stress signaling in virus-infected cells Herpesvirus latency and reactivation Recent Trends in Research Mohr's recent publications emphasize RNA modifications and translational regulation in herpesvirus infections, particularly HCMV and HSV-1. His work explores: Epitranscriptomic mechanisms in viral RNA accumulation Integration of stress response pathways with viral replication Computational approaches for RNA modification detection Role of nuclear body assembly in viral pathogenesis Laboratory Mohr leads the Mohr Lab at NYU Langone's virology research group. His lab collaborates extensively with other virology and RNA biology teams, particularly with Associate Professor Angus C. Wilson's lab, with which he has co-mentored trainees and secured joint grants.

Tyler Boldمشاهده پروفایل

دانشیار

• Infectious Diseases
• Immunology
• Microbiology
• +۳ مورد دیگر

Tyler Bold, MD, PhD serves as Associate Professor in the Division of Infectious Diseases and International Medicine within the Department of Medicine at the University of Minnesota Medical School. He concurrently holds faculty appointments in the Microbiology, Immunology and Cancer Biology (MICaB) Ph.D. Graduate Program and the Department of Medicine, establishing a multidisciplinary research presence spanning infectious disease pathogenesis, immunology, and host-pathogen interactions. His research program integrates clinical infectious disease expertise with fundamental immunological investigation, focusing on tuberculosis host-directed immunotherapy, SARS-CoV-2 pathogenesis mechanisms, and macrophage biology in atherosclerosis. Key interests include T cell costimulation in granulomatous diseases, viral-microbiome interactions during respiratory infections, and diagnostic innovations for resource-limited settings. His work bridges basic science discovery with translational clinical applications, particularly in immunocompromised populations and complex infectious syndromes. Analysis of his 15 most recent publications reveals dominant research trajectories in tuberculosis immunology (40% of articles), SARS-CoV-2 pathogenesis and therapeutics (35%), and atherosclerosis immunometabolism (15%), with emerging work on fungal infections in hematologic malignancies. The publications demonstrate consistent use of advanced techniques including single-cell resolution analysis, structural biology, and randomized clinical trials, reflecting both mechanistic depth and clinical relevance across infectious disease subspecialties.

Shelley L. Bergerمشاهده پروفایل

استاد

• Epigenetics
• Chromatin structure and function
• Histone modifications
• +۷ مورد دیگر

Shelley L. Berger is the Daniel S. Och University Professor at the University of Pennsylvania, holding a "Penn Integrates Knowledge" Presidential Appointment. She serves as Director of the Epigenetics Institute at the Perelman School of Medicine and is Co-Director of the Tumor Biology Program at the Abramson Cancer Center. Her academic appointments span multiple departments including Cell and Developmental Biology, Biology, and Genetics. Dr. Berger earned her B.S. in Biology from the University of Michigan, Ann Arbor in 1982, followed by a Ph.D. in Cell & Molecular Biology from the same institution in 1987. Her distinguished career has led to her current position as a University Professor, one of the highest academic honors at the University of Pennsylvania. Dr. Berger's research focuses on epigenetics and chromatin structure/function in genomic regulation, with particular interest in post-translational modifications of histones and transcription factors. Her laboratory investigates how DNA-packaging structures are manipulated during genomic processes, with applications to understanding cancer, neurodegeneration, and other diseases. Her work spans multiple biological contexts including: Chromatin regulation of transcription Neuroepigenetics and memory formation Behavioral epigenetics in social insects Chromatin regulation in aging and senescence Cancer epigenetics and tumor suppressor mechanisms Analysis of Dr. Berger's recent publications reveals a strong focus on the intersection of epigenetics with aging, cancer, and neurobiology. Her work demonstrates how histone modifications and chromatin remodeling influence cellular senescence, with implications for age-related diseases including Alzheimer's. She has also pioneered research on epigenetic mechanisms in social behavior using ant models, and in T cell exhaustion relevant to cancer immunotherapy. A unifying theme across her publications is the role of specific histone modifications and chromatin regulators in controlling gene expression programs in diverse biological contexts. Dr. Berger has received numerous honors including her appointment as a Daniel S. Och University Professor and a "Penn Integrates Knowledge" Presidential Appointment, recognizing her exceptional interdisciplinary contributions to science. These prestigious appointments reflect her significant impact on the fields of epigenetics and chromatin biology. Dr. Berger mentors a vibrant research team consisting of multiple postdoctoral researchers, graduate students, and research specialists. Her laboratory, part of the Epigenetics Institute at Penn, investigates fundamental mechanisms of chromatin regulation with implications for human health and disease. Current research directions include exploring how epigenetic mechanisms control aging processes, cancer development, and social behavior in model organisms. Dr. Berger collaborates extensively with other leading researchers, including Carl June (pioneer of CAR T cell therapy) and John Wherry (expert in T cell exhaustion), to translate basic epigenetic discoveries into potential therapeutic applications. The Berger Lab operates within the Smilow Center for Translational Research at the University of Pennsylvania. The lab employs a multidisciplinary approach combining molecular biology, genomics, bioinformatics, and model organism studies to investigate chromatin regulation. Current research foci include epigenetic mechanisms in aging and senescence, cancer epigenetics, neuroepigenetics, and behavioral epigenetics in social insects.

Nathan Wittenbergمشاهده پروفایل

دانشیار

• Bioanalytical Chemistry
• Membrane Biophysics
• Lipid Oxidation
• +۶ مورد دیگر

Nathan Wittenberg is an Associate Professor in the Department of Chemistry at Lehigh University , where he has been since 2016. His research focuses on bioanalytical chemistry and biomembrane interactions , particularly lipid bilayer dynamics and protein-lipid interactions crucial to nervous system function. Education: B.S. in Chemistry (University of Minnesota), Ph.D. in Chemistry (Pennsylvania State University) His work investigates: Modulation of protein-lipid interactions by membrane structure/composition Lipid oxidation effects on membrane properties and immune interactions Antibiotic resistance mechanisms in bacterial outer membrane vesicles Microfluidic and nanofabrication approaches for membrane analysis Recent publications highlight trends in biomembrane engineering , oxidized lipid dynamics , and extracellular vesicle characterization . Current students include Dane Santa (NSF Graduate Research Fellow) and Aarshi Singh . Awards include: NSF Graduate Research Fellowship (for student Dane Santa) Lab facilities span multiple Mudd Building locations (657, 589) with equipment for optical microscopy , mass spectrometry , and nanocontact printing . Collaborations bridge biochemistry , medical research , and engineering disciplines.